Haemonetics Corp (NYSE:HAE)
| 41.30 Data as of May 22 |  -0.51 / -1.22%Today’s Change | 32.69 Today|||52-Week Range 44.44 | +1.13% Year-to-Date |
Latest HAE News | Press Releases
| Interesting HAE Put For July May 20 / TheStreet.com | HAE Crosses Above Key Moving Average Level May 16 / TheStreet.com |
Today’s Trading
| Previous close | 41.81 |
| Today’s open | 41.83 |
| Day’s range | -- - -- |
| Volume | 497,562 |
| Average volume (3 months) | 301,969 |
| Market cap | $2.1B |
| Dividend yield | -- |
Data as of 4:01pm ET, 05/22/2013
Growth & Valuation
| Earnings growth (last year) | -16.99% |
| Earnings growth (this year) | +11.27% |
| Earnings growth (next 5 years) | +13.00% |
| Revenue growth (last year) | +7.56% |
| P/E ratio | 55.8 |
| Price/Sales | 2.43 |
| Price/Book | 2.85 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| WSTWest Pharmaceutical ... | -1.07 | -1.56% |
| PODDInsulet Corp | -1.05 | -3.53% |
| DXCMDexCom Inc | -0.77 | -3.64% |
| GMEDGlobus Medical Inc | -0.53 | -3.35% |
Data as of 4:05pm ET, 05/22/2013
Financials
| Next reporting date | August 5, 2013 |
| EPS forecast (this quarter) | $0.45 |
| Annual revenue (last year) | $727.8M |
| Annual profit (last year) | $66.9M |
| Net profit margin | 9.19% |
Profile
Sector Health Technology |
Industry Medical Specialties |
President, Chief Executive Officer & Director Brian P. Concannon |
Chief Financial Officer & VP-Business Development Christopher J. Lindop, CPA |
Corporate headquarters Braintree, Massachusetts |
Forecasts
